Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: Clin Cancer Res. 2021 Oct 1;27(19):5168–5187. doi: 10.1158/1078-0432.CCR-21-1259

Table 3:

Primary RT for FA-HNSCC Primaries

Patient Age Sex FA Group SCT (Age) Tumor site (subsite) Stage RT Dose Toxicities Interruption or Termination of RT Outcome Recurrence Second Primary
Anak #4 (2020)106 32 F NA Yes Esophagus (middle third) T2N0M0 45.9 Gy total (in 27 fractions) Mucositis, dysphagia, retrosternal pain, pneumonitis, esophageal stenosis No DOD (10 mo pD, 3 mo pRT) - Oral cavity
Lach #2 (2020)48 52 M A No Larynx T2N0M0 69 Gy total NA No Died of SP (esophagus) - Esophagus, Anus
Budrukkar 2009101 27 M NA No Pharynx (BOT) T2N0M0 70 Gy total (200 cGy x35 fractions) over 51 days Mucositis (grade 3), dermatitis (grade 3), leukopenia with fever No AWD (14 mo pD) Yes -
Han 200996 32 F NA No Oral cavity (retromolar trigone and hard palate), HPV+ NA [IMRT] 64.8 Gy total (in 27 fractions) Mucositis (grade 3), leukopenia (grade 4) No DOD (NA) - Vulva, cervix
Masserot #6 (2008)64 19.7 M NA Yes (7.3) Pharynx (oropharynx) T4N2cMX 70 Gy total Mucositis (grade 3), severe dehydration No DOD (4.5 mo pD) - -
Masserot #8 (2008)64 10.1 M NA Yes (4.6) Oral cavity (tongue) T3N0MX 25 Gy total over 4 weeks (vs. 65 Gy planned) Mucositis (severe) Yes (terminated) DOD (2.5 mo pD) - -
Horta 2006119 24 F NA No Pharynx (pyriform sinus) NA 19.8 Gy total Dysphagia, odynophagia, neutropenia, pneumonia Yes (terminated) DOD (NA) - -
Marcou 2001102 32 F A No Pharynx (tonsil) NA 34 Gy total in 17 fractions (vs. 60 Gy planned) Mucositis, ulceration, dysphagia, septicemia Yes (terminated) AWD (2 mo pRT) - -
Kozarek 1981120 26 M NA No Esophagus (cervical) NA 70 Gy total Laryngeal edema, pneumonia Yes (died during RT) DOD (during RT) - -